STOCK TITAN

TILT Sets First Quarter 2025 Conference Call for May 15 at 5:00 p.m. ET

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

TILT Holdings (OTCPK: TLLTF) has scheduled its first quarter 2025 earnings conference call for May 15, 2025, at 5:00 p.m. ET. The company, a global provider of cannabis business solutions specializing in inhalation technologies, cultivation, manufacturing, processing, brand development and retail, will release its financial results for the quarter ended March 31, 2025, prior to the call.

The conference call will feature TILT management presenting the company's business strategy and financial results, followed by a Q&A session. Participants can join using the toll-free number (877) 423-9813 or international number (201) 689-8573. A webcast replay will be available in the investor relations section of TILT's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-1.54%
1 alert
-1.54% News Effect

On the day this news was published, TLLTF declined 1.54%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PHOENIX, April 24, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (CBOE CA:TILT) (OTCPK: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that the Company will host a conference call on Thursday, May 15, 2025 at 5:00 p.m. Eastern Time to discuss its business strategy and financial results for the first quarter ended March 31, 2025. The Company’s results will be reported in a press release prior to the call.

TILT management will host the conference call, followed by a question-and-answer period. Interested parties can join the conference call by dialing in as directed below. Please dial-in 10 minutes prior to the call.

Date: Thursday, May 15, 2025
Time: 5:00 p.m. Eastern Time
Toll-free dial-in number: (877) 423-9813
International dial-in number: (201) 689-8573
Webcast: TILT Q1 2025 Earnings Call

The conference call will also be available for replay in the investor relations section of the Company’s website at www.tiltholdings.com.

About TILT

TILT Holdings manages a diverse portfolio of companies in the cannabis industry, encompassing technology, hardware, cultivation, and production. Its core business, Jupiter Research LLC, is a wholly owned subsidiary and a global distribution leader in the vaporization segment. Jupiter is dedicated to hardware design, research, development, and distribution to support cannabis brands and retailers across the United States, Canada, South America, and the European Union. Additionally, TILT is a multi-state operator, with cultivation and production facilities in three states under the Commonwealth Alternative Care and Standard Farms brands. For more information, visit www.tiltholdings.com.

Company Contact:

Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com

Investor Relations Contact:

Sean Mansouri, CFA
Elevate IR
TILT@elevate-ir.com
720.330.2829


FAQ

When is TILT Holdings (TLLTF) reporting Q1 2025 earnings?

TILT Holdings will report Q1 2025 earnings on May 15, 2025, at 5:00 p.m. Eastern Time.

How can investors access TILT Holdings' (TLLTF) Q1 2025 earnings call?

Investors can join via toll-free number (877) 423-9813, international number (201) 689-8573, or watch the webcast through TILT's investor relations website.

What period will TILT Holdings' (TLLTF) earnings report cover?

The earnings report will cover the first quarter ended March 31, 2025.

What business segments does TILT Holdings (TLLTF) operate in?

TILT operates in cannabis business solutions, including inhalation technologies, cultivation, manufacturing, processing, brand development, and retail.
Tilt Hldgs Inc

OTC:TLLTF

TLLTF Rankings

TLLTF Latest News

TLLTF Latest SEC Filings

TLLTF Stock Data

2.69M
322.44M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Phoenix